North America Insulin Delivery Market Outlook to 2033 – Insulin Pens and Insulin Pumps

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: February 20, 2026 Report Code: GDME21689CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Insulin Delivery Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Insulin Pens and Insulin Pumps

The North America Insulin Delivery Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Insulin Delivery Market.
• Global corporate-level profiles of key companies operating within the North America Insulin Delivery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Insulin Delivery is segmented as follows:_x000D_

• Insulin Pens_x000D_

• Insulin Pumps

Reasons to Buy

The North America Insulin Delivery Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Novo Nordisk AS
Eli Lilly and Co
Insulet Corp
Sanofi
Medtronic Plc
Tandem Diabetes Care Inc

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Insulin Delivery Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Insulin Delivery Market, North America

3.1 Insulin Delivery Market, North America, Revenue ($m), 2018-2033

3.2 Insulin Delivery Market, North America, Revenue ($m), 2018-2033

3.3 Insulin Delivery Market, North America, Volume (Units), 2018-2033

3.4 Insulin Delivery Market, North America, Volume (Units), 2018-2033

3.5 Insulin Delivery Market, North America, Company Share by Revenue ($m), 2025

4 Insulin Delivery Market, Canada

4.1 Insulin Delivery Market, Canada, Revenue ($m), 2018-2033

4.1.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2018-2033

4.1.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033

4.2 Insulin Delivery Market, Canada, Volume (Units), 2018-2033

4.2.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2018-2033

4.2.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2018-2033

4.3 Insulin Delivery Market, Canada, Average Price ($), 2018-2033

4.4 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2025

5 Insulin Delivery Market, Mexico

5.1 Insulin Delivery Market, Mexico, Revenue ($m), 2018-2033

5.1.1 Insulin Pens Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.1.2 Insulin Pumps Market, Mexico, Revenue ($m), by Segment, 2018-2033

5.2 Insulin Delivery Market, Mexico, Volume (Units), 2018-2033

5.2.1 Insulin Pens Market, Mexico, Volume (Units), by Segment, 2018-2033

5.2.2 Insulin Pumps Market, Mexico, Volume (Units), by Segment, 2018-2033

5.3 Insulin Delivery Market, Mexico, Average Price ($), 2018-2033

5.4 Insulin Delivery Market, Mexico, Company Share by Revenue ($m), 2025

6 Insulin Delivery Market, United States

6.1 Insulin Delivery Market, United States, Revenue ($m), 2018-2033

6.1.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2018-2033

6.1.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2018-2033

6.2 Insulin Delivery Market, United States, Volume (Units), 2018-2033

6.2.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2018-2033

6.2.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2018-2033

6.3 Insulin Delivery Market, United States, Average Price ($), 2018-2033

6.4 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2025

7 Overview of Key Companies in North America Insulin Delivery Market

7.1 Novo Nordisk AS

7.1.1 Company Overview

7.2 Eli Lilly and Co

7.2.1 Company Overview

7.3 Insulet Corp

7.3.1 Company Overview

7.4 Sanofi

7.4.1 Company Overview

7.5 Medtronic Plc

7.5.1 Company Overview

7.6 Tandem Diabetes Care Inc

7.6.1 Company Overview

8 Insulin Delivery Market Pipeline Products

9 Recent Developments

9.1 Corporate Communications

9.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work

9.1.2 Nov 21, 2025: Stroke Prevention Study CREST-2 Stenting

9.1.3 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors

9.1.4 Nov 17, 2025: Embecta Announces Changes to Board of Directors

9.1.5 Nov 05, 2025: Genesys Strike Negotiations Update

9.1.6 Oct 24, 2025: Payman Khales Becomes Integer President and CEO

9.1.7 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme

9.1.8 Oct 07, 2025: Tidepool Joins Milken Institute’s Women’s Health Network as Inaugural Member

9.1.9 Sep 29, 2025: MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

9.1.10 Sep 25, 2025: Joe Hedges Appointed New Associate Director of David G. Pollart Center for Arts and Humanities

9.1.11 Sep 16, 2025: Insulet Announces CFO Appointment

9.1.12 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

9.1.13 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

9.1.14 Apr 28, 2025: Insulet Appoints Ashley McEvoy President and CEO

9.1.15 Jan 06, 2025: MannKind Expands Executive Leadership Team

9.2 Financial Announcements

9.2.1 Nov 05, 2025: Fractyl Health to Report Third Quarter 2025 Financial Results and Business Updates

9.2.2 Oct 30, 2025: Lilly Reports Third-Quarter 2025 Financial Results, Highlights R&D Pipeline Momentum and Raises 2025 Guidance

9.2.3 Oct 09, 2025: Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

9.2.4 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results

9.2.5 Aug 08, 2025: Embecta Announces Q3 Fiscal 2025 Results

9.2.6 Aug 07, 2025: Lilly Announces Q2 2025 Results and Raises Guidance

9.2.7 Aug 07, 2025: Insulet Reports Second Quarter 2025 Revenue Increase of

32.9% Year-Over-Year (31.3% Constant Currency)

9.2.8 Jul 24, 2025: Lilly Confirms Date and Conference Call for Second-Quarter 2025 Financial Results Announcement

9.2.9 Jul 24, 2025: Embecta to Report Fiscal Third Quarter 2025 Financial Results

9.2.10 Jul 09, 2025: Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

9.2.11 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results

9.2.12 Mar 28, 2025: Retractable Technologies Announces Results for 2024

9.2.13 Feb 19, 2025: MannKind Corp to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

9.2.14 Jan 23, 2025: embecta to Report Fiscal First Quarter 2025 Financial Results

9.3 Government and Public Interest

9.3.1 Dec 01, 2025: Fractyl Health to Participate in 8th Annual Evercore Healthcare Conference

9.3.2 Nov 03, 2025: Beta Bionics Announces Participation at Upcoming Investor Conferences

9.3.3 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results

9.3.4 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD

9.3.5 Aug 22, 2025: Lilly to Participate in Wells Fargo 20th Annual Healthcare Conference

9.3.6 Aug 21, 2025: Beta Bionics Announces Participation at Upcoming Investor Conferences

9.3.7 Aug 19, 2025: Insulet to Participate in Upcoming Investor Conferences

9.3.8 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4

9.3.9 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

9.3.10 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

9.3.11 Feb 13, 2025: Tandem Diabetes Care Announces Upcoming Conference Presentations

9.3.12 Feb 06, 2025: MannKind to Present at Upcoming Investor Conferences

9.3.13 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference

9.3.14 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

9.4 Other Significant Developments

9.4.1 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes

9.4.2 Apr 23, 2025: Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research

9.4.3 Feb 04, 2025: As Major Insulin Producers Shift Focus, Rbio Steps up To Address Potential Shortages

9.4.4 Dec 20, 2024: Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

9.5 Product News

9.5.1 Nov 22, 2025: Insul-eze Syringe Magnifier 2x Magnification for Easy Viewing

9.5.2 Nov 20, 2025: Stanley Hsia, MD, Presents Phase 2 Trial Results for Mazdutide

9.5.3 Nov 20, 2025: University Hospitals Approved as U.S. Site and Only Ohio Site to Administer Lantidra for Type 1 Diabetes

9.5.4 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes

9.5.5 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation

9.5.6 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment

9.5.7 Oct 08, 2025: Ithaca Startup Seeks To Alleviate Daily Burden For Diabetes Patients

9.5.8 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment

9.5.9 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes

9.5.10 Sep 29, 2025: Novo Nordisk Resubmits Awiqli® to the FDA for Once-Weekly Basal Insulin for Type 2 Diabetes

9.5.11 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD

9.5.12 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes

9.5.13 Sep 09, 2025: Lilly Introduces TuneLab Platform To Enhance AI-Enabled Drug Discovery Access For Biotech Companies

9.5.14 Apr 01, 2025: Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

9.6 Strategy And Business Planning

9.6.1 Oct 08, 2025: Enovis Completes Sale of Dr. Comfort Footcare Solutions Business for Up to $60 Million

9.6.2 Oct 07, 2025: Tidepool Joins Milken Institute’s Women’s Health Network as Inaugural Member

9.6.3 Sep 09, 2025: Lilly Introduces TuneLab Platform To Enhance AI-Enabled Drug Discovery Access For Biotech Companies

10 Appendix

10.1 Research Methodology

10.1.1 Coverage

10.1.2 Secondary Research

10.1.3 Primary Research

10.1.4 Market Modeling and Forecasting

10.1.5 Company Share Analysis

10.1.6 Benchmarking

10.2 GlobalData Consulting

10.3 Contact Us

10.4 Disclaimer

Table

Table 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Table 2: Insulin Delivery Market, North America, Revenue ($m), USD Constant, 2018-2033

Table 3: Insulin Delivery Market, North America, Volume (Units), 2018-2033

Table 4: Insulin Delivery Market, North America, Volume (Units), 2018-2033

Table 5: Insulin Delivery Market, North America, Company Share by Revenue ($m), 2025

Table 5: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 6: Insulin Pens Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 7: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033

Table 8: Insulin Delivery Market, Canada, Volume (Units), 2018-2033

Table 9: Insulin Pens Market, Canada, Volume (Units), 2018-2033

Table 10: Insulin Pumps Market, Canada, Volume (Units), 2018-2033

Table 11: Insulin Delivery Market, Canada, Average Price ($), 2018-2033

Table 12: Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2025

Table 13: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 14: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 15: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Table 16: Insulin Delivery Market, Mexico, Volume (Units), 2018-2033

Table 17: Insulin Pens Market, Mexico, Volume (Units), 2018-2033

Table 18: Insulin Pumps Market, Mexico, Volume (Units), 2018-2033

Table 19: Insulin Delivery Market, Mexico, Average Price ($), 2018-2033

Table 20: Insulin Delivery Market, Mexico, Company Share by Revenue ($m), 2025

Table 21: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 22: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 23: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 24: Insulin Delivery Market, United States, Volume (Units), 2018-2033

Table 25: Insulin Pens Market, United States, Volume (Units), 2018-2033

Table 26: Insulin Pumps Market, United States, Volume (Units), 2018-2033

Table 27: Insulin Delivery Market, United States, Average Price ($), 2018-2033

Table 28: Insulin Delivery Market, United States, Company Share by Revenue ($m), 2025

Table 29: Insulin Delivery Market Pipeline Products

Figures

Figure 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033

Figure 2: Insulin Delivery Market, North America, Revenue ($m), USD Constant, 2018-2033

Figure 3: Insulin Delivery Market, North America, Volume (Units), 2018-2033

Figure 4: Insulin Delivery Market, North America, Volume (Units), 2018-2033

Figure 5: Insulin Delivery Market, North America, Company Share (%), 2025

Figure 5: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 6: Insulin Pens Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 7: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033

Figure 8: Insulin Delivery Market, Canada, Volume (Units), 2018-2033

Figure 9: Insulin Pens Market, Canada, Volume (Units), 2018-2033

Figure 10: Insulin Pumps Market, Canada, Volume (Units), 2018-2033

Figure 11: Insulin Delivery Market, Canada, Company Share (%), 2025

Figure 12: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 13: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 14: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, 2018-2033

Figure 15: Insulin Delivery Market, Mexico, Volume (Units), 2018-2033

Figure 16: Insulin Pens Market, Mexico, Volume (Units), 2018-2033

Figure 17: Insulin Pumps Market, Mexico, Volume (Units), 2018-2033

Figure 18: Insulin Delivery Market, Mexico, Company Share (%), 2025

Figure 19: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 20: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 21: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 22: Insulin Delivery Market, United States, Volume (Units), 2018-2033

Figure 23: Insulin Pens Market, United States, Volume (Units), 2018-2033

Figure 24: Insulin Pumps Market, United States, Volume (Units), 2018-2033

Figure 25: Insulin Delivery Market, United States, Company Share (%), 2025

North America Insulin Delivery Market Outlook to 2033 – Insulin Pens and Insulin Pumps standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Diabetes Care Devices reports

Medical Devices

New

Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Insulin Delivery Market Outlook to 2033 – Insulin Pens and Insulin Pumps in real time.

Access a live North America Insulin Delivery Market Outlook to 2033 – Insulin Pens and Insulin Pumps dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Insulin Delivery Market Outlook to 2033 – Insulin Pens and Insulin Pumps

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports